V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
Vol.41 No.5 • 9/2024
DAILY CLINICAL LAB NEWS
®
I
N
T
E
R
N
A
T
I
O
Sepsis Testing Reduced From Days to Hours
Rapid Method for Determining Virus Infectivity Can Revolutionize Response to Future Pandemics
epsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death. It holds a 30day mortality rate of over 30%,
O
S
n average, every four years a new virus emerges that poses a pandemic threat, in addition to numerous already known viruses that have the potential to jump across species. Currently, there is no test that can quickly determine whether a virus in a sample is
intact and potentially infectious, or damaged and non-infectious, without requiring weeks of cell culture. The traditional method for assessing viral infectivity involves the use of cultured cells, which not only takes days to yield results but also requires special-
Cont’d on page 2
Cont’d on page 9
Roundup ADLM 2024 Roundup:
N
A
L
POC Detection of Stroke within Minutes ach year, more than 20 million people worldwide suffer from strokes. Large vessel occlusions (LVO) constitute 30% of these cases but are behind 95% of the resulting disabilities and fatalities. The likelihood of recovery improves significantly if a procedure known as ‘thrombectomy’ is performed immediately after the onset of symptoms. However, speeding up this treatment is
E
Cont’d on page 10
Innovations Shaping Shaping the the Future Future Innovations of Clinical Clinical Diagnostics Diagnostics of
Test Predicts Organ Transplant Outcomes
he world’s largest in vitro diagnostics meeting was held on July 28-August 1 in Chicago. LabMedica’s editors review highlights of the technical exhibition, showcasing latest innovations in the field.
T
n a landmark study, an interdisciplinary research team from the Westmead Institute for Medical Research (WIMR, NSW, Australia; www.westmead institute.org.au) and the University of Sydney (NSW, Australia; www.sydney.edu.au) has identified, for the first time, common molecular biomarkers for transplant rejection across major transplanted organs, including hearts,
I
See article on page 4
Cont’d on page 12
V
I
S
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information:
Portable Device Monitors Cancer Patient Health
Cont’d on page 13
®
Mark code(s) of interest on 3 LinkXpress ® inquiry matrix If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
ADLM ’24 Roundup . . . 4
hemotherapy and similar treatments aimed at eliminating cancer cells often adversely affect patients’ immune cells. Each year, this results in tens of thousands of cancer patients suffering from weakened immune systems, making them susceptible to potentially fatal infections. Physicians are tasked
C
Identify LinkXpress codes of 1 interest as you read magazine on LinkXpress.com 2 toClick reach reader service portal
INSIDE
M
Protein Signatures in Blood Can Predict Risk of Over 60 Diseases
easuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements from a small blood sample to predict a
variety of diseases. In the research, published in Nature Medicine, which was carried out as part of an international partnership involving Queen Mary University of London (London, UK; www.qmul.ac.uk), the investigators used data from the Cont’d on page 12
LabMedica EXPO . 6-16 Clinical News . . . . 2 -16 IFCC News . . . . 17-21 Industry News .. . . . 21 Events Calendar . . 22 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<